Results 41 to 50 of about 1,296 (182)

Interaction between amrinone and parathyroid hormone on bone in culture

open access: yes, 1982
The cardiotonic agent amrinone has been postulated to directly affect Na-Ca exchange. Because stimulated bone resorption has been proposed to require Na-Ca exchange, we examined the effects of amrinone on bone.
P. H. Stern, N. S. Krieger
core   +1 more source

Postoperative Arrhythmias after Cardiac Surgery: Incidence, Risk Factors, and Therapeutic Management

open access: yesCardiology Research and Practice, Volume 2014, Issue 1, 2014., 2014
Arrhythmias are a known complication after cardiac surgery and represent a major cause of morbidity, increased length of hospital stay, and economic costs. However, little is known about incidence, risk factors, and treatment of early postoperative arrhythmias. Both tachyarrhythmias and bradyarrhythmias can present in the postoperative period.
Giovanni Peretto   +4 more
wiley   +1 more source

Continuous Selective Intra‐Arterial Application of Nimodipine in Refractory Cerebral Vasospasm due to Aneurysmal Subarachnoid Hemorrhage

open access: yesBioMed Research International, Volume 2014, Issue 1, 2014., 2014
Background. Cerebral vasospasm is one of the leading courses for disability in aneurysmal subarachnoid hemorrhage. Effective treatment of vasospasm is therefore one of the main priorities for these patients. We report about a case series of continuous intra‐arterial infusion of the calcium channel antagonist nimodipine for 1–5 days on the intensive ...
Stephanie Ott   +8 more
wiley   +1 more source

Actions of amrinone and milrinone on the guinea-pig ileum

open access: yes, 1988
The pharmacological activity of the cardiotonic agents amrinone and milrinone has been examined on the isolated guinea-pig ileum. Both compounds antagonised the presynaptic inhibitory action of adenosine on electrically evoked contractions, milrinone ...
D M Paton, T W Stone
core   +1 more source

Pancytopenia Secondary to Short-Term, High-Dose Intravenous Infusion of Amrinone

open access: yes, 1990
The incidence of amrinone-induced thrombocytopenia has been reported to be 2.4 percent in patients receiving intravenous therapy. To date there have been no reports of bleeding in these patients nor have there been reports of other hematologic ...
Mark W. Weston   +3 more
core   +1 more source

Efficacy of different cardiotonic drug on severity of endotoxemia under heart failure coupled with systemic inflammatory syndrome in experiments

open access: yesКубанский научный медицинский вестник, 2015
On the model of systemic inflammatory response syndrome caused by toxi-allergic myocarditis 10-day duration in rabbits the efficacy of 5 days (beginning after 5 days from the injection of staphylococcus toxins) administration of the various ...
D. I. Ionov   +4 more
doaj  

Amrinone prevents muscle protein wasting during chronic sepsis

open access: yes, 1995
The time course for the effects of sepsis on rates of protein synthesis, RNA contents, and translational efficiencies was measured in mixed muscles of rat hindlimb perfused in vitro 3, 5, and 10 days after induction of sepsis.
C. V. Jurasinski   +2 more
core   +1 more source

Effects of amrinone on shortening velocity and force development in skinned skeletal muscle fibres.

open access: yes, 1993
The effects of amrinone were studied on single skinned fibres isolated from rat hindlimb muscles. In each fibre a force-velocity relation was determined during maximal calcium activation (pCa = 4.45) in control conditions and in the presence of amrinone.
V. Cappelli   +5 more
core   +1 more source

Vesnarinone and amrinone reduce the systemic inflammatory response syndrome [PDF]

open access: yes, 1999
Objective: The systemic inflammatory response is an important cause of organ dysfunction. The present study tested the hypothesis that 2 clinically used agents, amrinone and vesnarinone, would decrease inflammation and cardiac dysfunction in a relevant ...
del Nido, Pedro J.   +8 more
core   +1 more source

Clinical Observation on the Patients with Congestive Heart Failure Given Amrinone

open access: yesHuli yanjiu, 1996
我科1993年2月至1994年7月对40例充血性心力衰竭患者,在采取卧床休息、限制食盐、用洋地黄类强心剂、利尿剂和扩血管剂治疗无效后,加用或改用氨吡酮(氨力农)静脉给药,获得满意的效果。现将治疗方法与护理体会报告如下。 1 临床资料本组40例均为住院病人。男27例,女13例;年龄10~83岁。其中风湿性心脏病12例,扩张型心肌病3例,冠心病21例,先天性心脏病1例,高血压性心脏病2例,肺原性心脏病1例。
杨秋凤, 朱秀清
doaj  

Home - About - Disclaimer - Privacy